Jamieson Wellness (TSE:JWEL) Trading at C$45.44

Key Points

• Jamieson Wellness shares were essentially flat at C$45.44 in mid-day trading, while volume rose 46% above the average session level.
• Analysts have generally turned more cautious, with four of five covering firms rating the stock Hold or Tender. The consensus price target is C$46.54, modestly above the current price.
• The company reported quarterly EPS of C$0.46 on C$233.84 million in revenue and increased its quarterly dividend to C$0.25 per share, implying a 2.2% annualized yield.

Jamieson Wellness Inc. (TSE:JWEL - Get Free Report)'s stock price traded up 0% during mid-day trading on Friday. The company traded as high as C$45.48 and last traded at C$45.44. 204,165 shares changed hands during mid-day trading, an increase of 46% from the average session volume of 139,669 shares. The stock had previously closed at C$45.43.

Wall Street Analysts Forecast Growth

Several analysts have commented on JWEL shares. Royal Bank Of Canada cut Jamieson Wellness from an "outperform" rating to a "sector perform" rating and lowered their price target for the company from C$46.00 to C$45.75 in a report on Monday, August 10th. Canaccord Genuity Group lowered shares of Jamieson Wellness from a "buy" rating to a "hold" rating and increased their price objective for the stock from C$44.50 to C$45.75 in a report on Monday, August 10th. Canadian Imperial Bank of Commerce cut shares of Jamieson Wellness from an "outperformer" rating to a "tender" rating and raised their target price for the stock from C$44.00 to C$45.75 in a research report on Friday, August 7th. TD downgraded shares of Jamieson Wellness from a "buy" rating to a "hold" rating and boosted their target price for the company from C$48.00 to C$49.00 in a report on Monday, August 10th. Finally, National Bank Financial lowered shares of Jamieson Wellness from an "outperform" rating to a "tender" rating and dropped their price target for the stock from C$51.00 to C$45.75 in a research report on Monday, August 31st. One research analyst has rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of C$46.54.

Jamieson Wellness Stock Up 0.0%

The firm has a market capitalization of C$1.89 billion, a PE ratio of 24.83 and a beta of 1.41. The company has a current ratio of 3.41, a quick ratio of 1.08 and a debt-to-equity ratio of 93.69. The firm has a 50-day moving average of C$44.42 and a two-hundred day moving average of C$38.93.

Jamieson Wellness (TSE:JWEL - Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported C$0.46 earnings per share (EPS) for the quarter. The firm had revenue of C$233.84 million during the quarter. Jamieson Wellness had a return on equity of 15.93% and a net margin of 8.92%. On average, equities research analysts forecast that Jamieson Wellness Inc. will post 2.1438892 EPS for the current year.

Jamieson Wellness Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 15th. Investors of record on Tuesday, September 15th were given a dividend of $0.25 per share. This is a boost from Jamieson Wellness's previous quarterly dividend of $0.23. The ex-dividend date of this dividend was Monday, August 31st. This represents a $1.00 dividend on an annualized basis and a yield of 2.2%. Jamieson Wellness's dividend payout ratio is currently 50.27%.

Jamieson Wellness Company Profile

Jamieson Wellness Inc is engaged in the manufacturing, distributing, and marketing of branded natural health products, including vitamins, minerals, and supplements. The company operates in two segments: The Jamieson brands and The Strategic Partners. The majority of its revenue comes from the Jamieson brand segment. Some of its brands are Jamieson, Progressive, Precision, and Iron Vegan. Geographically, most of its revenue is derived from the domestic market.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.